Royal Bank of Scotland Group PLC
28 February 2007
28 February 2007
The Royal Bank of Scotland plc - Publication of Supplement
The following Supplement has been approved as a supplement by the UK Listing
Authority and is available for viewing:
Supplement dated 27 February 2007 (the 'Supplement') relating to an issue of
4,000 Discount Securities linked to the Dow Jones Euro Stoxx(R) 50 (Price) Index
supplementing the Prospectus (the 'Prospectus') dated 20 September 2006 (as
supplemented by a supplemental prospectus dated 20 December 2006) relating to
the Certificate and Warrant Programme of The Royal Bank of Scotland plc.
To view the full document, please paste the following URL into the address bar
of your browser.
Supplement
http://www.rns-pdf.londonstockexchange.com/rns/0691s_-2007-2-28.pdf
The full document is also available for viewing at the Document Viewing Facility
of the UK Listing Authority.
This website is not provided for, or directed at, U.S. persons or persons in the
United States. If you are a U.S. person or are viewing this page from the United
States, you should exit this section of the website.
For further information, please contact:
Peter Nielsen
c/o Group Legal, GBM
RBS Global Banking & Markets
135 Bishopsgate
London EC2M 3UR
Tel: +44(0)20 7085 5000
Fax:+44(0)20 7085 8411
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Prospectus, as supplemented by
the Supplement may be addressed to and/or targeted at persons who are residents
of particular countries (specified in the Prospectus) only and is not intended
for use and should not be relied upon by any person outside these countries and/
or to whom the offer contained in the Prospectus is not addressed. Prior to
relying on the information contained in the Prospectus, as so supplemented, you
must ascertain from the Prospectus whether or not you are part of the intended
addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above
requirement.
The Supplement on this website does not constitute an offer of securities for
sale in the United States. Any securities issued pursuant thereto have not been,
and will not be, registered under the U.S. Securities Act of 1933, as amended
(the 'Securities Act'), or under any relevant securities laws of any state of
the United States of America, and may not be offered or sold to U.S. persons or
to persons within the United States of America, except pursuant to an exemption
from the Securities Act.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.